// App-Quantinova.ai

: SERIAL ASSESSMENT OF BIOMARKERS AND THE RISK OF HEART FAILURE IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ENGAGE AF-TIMI 48 TRIAL

Researchers

Presenter

  • Kazuma Oyama

Principal Investigators

  • Robert P. Giugliano

  • Christian Ruff

  • David Berg

  • Minao Tang

  • Hans Joachim Lanz

  • Elliott M. Antman

  • Eugene Braunwald

  • David A. Morrow

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Congestive heart failure

Biomarkers

  • B-type natriuretic peptide

  • Growth differentiation factor 15

  • N-terminal pro b-type natriuretic peptide

  • High-sensitivity cardiac troponin T

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved